Literature DB >> 1127497

Classic phenylketonuria: diagnosis through heterozygote detection.

R F Griffin, L J Elsas.   

Abstract

Fifty-nine male and female (pregnant and nonpregnant) normal control subjects were differentiated from 18 male and female obligate heterozygotes for classic PKU. The method of genotyping utilized midday semifasting blood P and T quantitated by ion-exchange chromatography, an empiric determinant, P-2/T, and a discriminant function (sigma), in which sigma = a(1)(P)+a(2)(T);a(1) and a(2) were computed by multivariate analysis, This method of genotyping was applied in three clinical settings. In one family hyperphenylalaninemia was differentiated from classic PKU in two sisters with elevated blood P. In a second family maternal PKU was related to microcephaly in two retarded siblings, one of whom was also homozygous for classic PKU. In a third family a diagnosis of classic PKU was established in a normal-appearing infant whose blood P concentration was elevated.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127497     DOI: 10.1016/s0022-3476(75)80139-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Study of restriction fragment length polymorphisms at the human phenylalanine hydroxylase locus and evaluation of its potential application in prenatal diagnosis of phenylketonuria in Chinese.

Authors:  S H Chen; K J Hsiao; L H Lin; T T Liu; R B Tang; T S Su
Journal:  Hum Genet       Date:  1989-02       Impact factor: 4.132

2.  Heterozygous carriers of classical phenylketonuria in a sample of the Turkish population: detection by a spectrofluorimetric method.

Authors:  F Güneral; I Ozalp; H Tatlidil
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  Significant phenylalanine hydroxylation in vivo in patients with classical phenylketonuria.

Authors:  G N Thompson; D Halliday
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

4.  Influence of the phenylalanine dose on the aromatic acid excretion in phenylketonuric heterozygotes and controls after oral loading.

Authors:  G Dahmann; K Olek; A Pravitz; P Wardenbach
Journal:  Eur J Pediatr       Date:  1978-10-12       Impact factor: 3.183

5.  Absent phenylalanine hydroxylase activity without phenylketonuria.

Authors:  M Yudkoff; S Segal
Journal:  Eur J Pediatr       Date:  1980-06       Impact factor: 3.183

6.  Phenylketonuria heterozygote detection in families with affected children.

Authors:  T D Paul; I K Brandt; L J Elsas; C E Jackson; P Mamunes; C S Nance; W E Nance
Journal:  Am J Hum Genet       Date:  1978-05       Impact factor: 11.025

7.  Biopterin defect in a normal-appearing child affected by a transient phenylketonuria.

Authors:  F Rey; R J Leeming; J A Blair; J Rey
Journal:  Arch Dis Child       Date:  1980-08       Impact factor: 3.791

Review 8.  Diseases of phenylalanine metabolism.

Authors:  C E Parker
Journal:  West J Med       Date:  1979-10

9.  Carrier screening for phenylketonuria: comparison of two discriminant analysis procedures.

Authors:  C L Freehauf; D Lezotte; S I Goodman; E R McCabe
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.